{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T01:50:38Z","timestamp":1791337838210,"version":"4.3.1"},"reference-count":15,"publisher":"Academy of Managed Care Pharmacy","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JMCP"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.18553\/jmcp.2026.32.3.392","type":"journal-article","created":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T03:23:21Z","timestamp":1772249001000},"page":"392-397","source":"Crossref","is-referenced-by-count":2,"title":["The effectiveness and value of brensocatib for the treatment of non\u2013cystic fibrosis bronchiectasis"],"prefix":"10.18553","volume":"32","author":[{"given":"Avery","family":"McKenna","sequence":"first","affiliation":[{"name":"Institute for Clinical and Economic Review, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason H.","family":"Wasfy","sequence":"additional","affiliation":[{"name":"Mass General Brigham and Harvard Medical School, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kibum","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Systems, Outcomes and Policy, University of Illinois Chicago"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel R.","family":"Touchette","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Systems, Outcomes and Policy, University of Illinois Chicago"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sodam","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Systems, Outcomes and Policy, University of Illinois Chicago"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Richardson","sequence":"additional","affiliation":[{"name":"Institute for Clinical and Economic Review, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel A.","family":"Ollendorf","sequence":"additional","affiliation":[{"name":"Institute for Clinical and Economic Review, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7818","reference":[{"key":"r1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(21)00277-0"},{"key":"r2","first-page":"6","volume":"147","author":"Cole PJ","year":"1986","journal-title":"Eur J Respir Dis Suppl"},{"key":"r3","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00629-2017"},{"key":"r4","doi-asserted-by":"publisher","DOI":"10.1177\/1479972317709649"},{"key":"r5","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2023.06.040"},{"key":"r6","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201309-1575OC"},{"key":"r7","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2018-212463"},{"key":"r8","unstructured":"Food and Drug Administration. BRINSUPRI(TM) (brensocatib). Prescribing information. 2025."},{"key":"r9","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2411664"},{"key":"r10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2021713"},{"key":"r11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2014.01.007"},{"key":"r12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0247941"},{"issue":"2","key":"r13","first-page":"96","volume":"18","author":"Windegger TM","year":"2020","journal-title":"Blood Transfus"},{"key":"r14","doi-asserted-by":"crossref","unstructured":"Bhattacharyya SBCF, Priedane E, Shirore RM, et al. De-Novo Economic Model to Assess Clinical and Economic Consequences of Bronchiectasis. Paper presented at: Value in Health; International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Annual Conference; 2014.","DOI":"10.1016\/j.jval.2014.08.1799"},{"key":"r15","unstructured":"Gardner J. Insmed gains US approval of lung disease drug forecast to be blockbuster. Industry Dive. BioPharma Dive. Published 2025. Accessed September 03, 2025. https:\/\/www.biopharmadive.com\/news\/insmed-fda-approval-brinsupri-brensocatib-bronchiectasis\/757476\/"}],"container-title":["Journal of Managed Care & Specialty Pharmacy"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T03:23:37Z","timestamp":1772681017000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jmcp.org\/doi\/10.18553\/jmcp.2026.32.3.392"}},"subtitle":["A summary from the Institute for Clinical and Economic Review\u2019s California Technology Assessment Forum"],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":15,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["10.18553\/jmcp.2026.32.3.392"],"URL":"https:\/\/doi.org\/10.18553\/jmcp.2026.32.3.392","relation":{},"ISSN":["2376-0540","2376-1032"],"issn-type":[{"value":"2376-0540","type":"print"},{"value":"2376-1032","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3]]}}}